Document Actions
Vicki Marsh
Recent Publications
- Aubya TO, Rowa Y, Mutemi W, Ochola S, Molyneux Sassy, and Marsh Vicki (2010) Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya BMC Public Health, 10(93).
- Molyneux Sassy, Kamuya D, and Marsh Vicki (2010) Community members employed on research projects face crucial, often under-recognised, ethical dilemmas (invited commentary) American Journal of Bioethics, 10(3):24.
- Abuya TO, Fegan G, Rowa Y, Baya EK, Mutemi WM, Ochola SA, and Marsh Vicki (2009) The Impact of Ministry of Health Interventions on Private Medicine Retailer Knowledge and Practices on Anti-malarial Treatment in Kenya American Journal of Tropical Medicine and Hygiene, 80(6):905-913.
- Gikonyo C, Bejon P, Marsh Vicki, and Molyneux Sassy (2008) Taking Social relationships seriously:Lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast Social Science and Medicine, 67(5):708-720.
- Marsh Vicki, Kamuya D, Gikonyo C, Rowa Y, and Molyneux Sassy (2008) Beginning community engagement at a busy biomedical research programme: Experiences from KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi Social Science and Medicine(67):721-733.
| vicki.marsh@ndm.ox.ac.uk | |
| Tel | 01865 287887 |
| Contact address | The Ethox Centre, Department of Public Health, University of Oxford, Old Road Campus, Oxford OX3 7LF. |
| College | Kellogg College |
Vicki is a member of the Social and Behavioural Research Group at the KEMRI (Kenya Medical Research Institute)-Wellcome Trust Research Programme in Kilifi, Kenya, and is registered through the Ethox Centre for a DPhil in Public Health. Her research aims to take forwards ethical debates around screening for sickle cell disorder (SCD) in Africa in the context of population based genetics or genomics research and health care provision. SCD is an inherited disorder with a high burden of morbidity and mortality in Africa for which diagnostic screening is practised and predictive screening has been recommended. Associated ethical, legal and social implications (ELSI) of genetic screening, including SCD, are well described globally. However, there is relatively little empirical data from Africa on the social and ethical implications of genetic screening to support research and service policy. This research is being conducted in two phases to:
Phase one:Explore ground realities for families who undergo predictive or diagnostic SCD testing, including both affected and unaffected families. This phase draws mainly on 22 in-depth narrative interviews, conducted in 2009 and analysed inductively to identify key social and ethical issues from participants’ perspectives. Quantitative data from a randomized sample of household in 2010 will be used triangulate some qualitative findings.
Phase two:Undertake an ethical analysis around key issues in predictive and diagnostic SCD testing in Africa, including:
· What communication strategies should be adopted during diagnostic testing of symptomatic children?
· Should carrier results be disclosed during predictive screening of healthy populations?
Biography
Vicki has worked in clinical medicine and general practice in the UK (DCH, MRCGP, DTM&H) after graduating from the University of Liverpool. She spent 3 years working in tropical paediatrics in the Gambia between 1981 and 1984, and moved to Kenya in 1990 to support the clinical research programme at the Kilifi centre, which is part of the Oxford Tropical Network. Since 1994, she has worked on community health issues, including the role of the informal private sector in malaria control, and more recently on the role of community engagement in strengthening ethical practice in international biomedical research
